Request for Covid-19 Impact Assessment of this Report
The United States Montelukast API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Montelukast API market, reaching US$ million by the year 2028. As for the Europe Montelukast API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Montelukast API players cover Merck, Cipla, Morepen Laboratories, and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablet
Chewable Tablet
Oral Solution
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Asthma
Allergic Rhinitis
Urticaria
Bronchospasm
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Montelukast API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Montelukast API by Country/Region, 2017, 2022 & 2028
2.2 Montelukast API Segment by Type
2.2.1 Tablet
2.2.2 Chewable Tablet
2.2.3 Oral Solution
2.3 Montelukast API Sales by Type
2.3.1 Global Montelukast API Sales Market Share by Type (2017-2022)
2.3.2 Global Montelukast API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Montelukast API Sale Price by Type (2017-2022)
2.4 Montelukast API Segment by Application
2.4.1 Asthma
2.4.2 Allergic Rhinitis
2.4.3 Urticaria
2.4.4 Bronchospasm
2.4.5 Others
2.5 Montelukast API Sales by Application
2.5.1 Global Montelukast API Sale Market Share by Application (2017-2022)
2.5.2 Global Montelukast API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Montelukast API Sale Price by Application (2017-2022)
3 Global Montelukast API by Company
3.1 Global Montelukast API Breakdown Data by Company
3.1.1 Global Montelukast API Annual Sales by Company (2020-2022)
3.1.2 Global Montelukast API Sales Market Share by Company (2020-2022)
3.2 Global Montelukast API Annual Revenue by Company (2020-2022)
3.2.1 Global Montelukast API Revenue by Company (2020-2022)
3.2.2 Global Montelukast API Revenue Market Share by Company (2020-2022)
3.3 Global Montelukast API Sale Price by Company
3.4 Key Manufacturers Montelukast API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast API Product Location Distribution
3.4.2 Players Montelukast API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast API by Geographic Region
4.1 World Historic Montelukast API Market Size by Geographic Region (2017-2022)
4.1.1 Global Montelukast API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Montelukast API Annual Revenue by Geographic Region
4.2 World Historic Montelukast API Market Size by Country/Region (2017-2022)
4.2.1 Global Montelukast API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Montelukast API Annual Revenue by Country/Region
4.3 Americas Montelukast API Sales Growth
4.4 APAC Montelukast API Sales Growth
4.5 Europe Montelukast API Sales Growth
4.6 Middle East & Africa Montelukast API Sales Growth
5 Americas
5.1 Americas Montelukast API Sales by Country
5.1.1 Americas Montelukast API Sales by Country (2017-2022)
5.1.2 Americas Montelukast API Revenue by Country (2017-2022)
5.2 Americas Montelukast API Sales by Type
5.3 Americas Montelukast API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast API Sales by Region
6.1.1 APAC Montelukast API Sales by Region (2017-2022)
6.1.2 APAC Montelukast API Revenue by Region (2017-2022)
6.2 APAC Montelukast API Sales by Type
6.3 APAC Montelukast API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast API by Country
7.1.1 Europe Montelukast API Sales by Country (2017-2022)
7.1.2 Europe Montelukast API Revenue by Country (2017-2022)
7.2 Europe Montelukast API Sales by Type
7.3 Europe Montelukast API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast API by Country
8.1.1 Middle East & Africa Montelukast API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Montelukast API Revenue by Country (2017-2022)
8.2 Middle East & Africa Montelukast API Sales by Type
8.3 Middle East & Africa Montelukast API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast API
10.3 Manufacturing Process Analysis of Montelukast API
10.4 Industry Chain Structure of Montelukast API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast API Distributors
11.3 Montelukast API Customer
12 World Forecast Review for Montelukast API by Geographic Region
12.1 Global Montelukast API Market Size Forecast by Region
12.1.1 Global Montelukast API Forecast by Region (2023-2028)
12.1.2 Global Montelukast API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast API Forecast by Type
12.7 Global Montelukast API Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Montelukast API Product Offered
13.1.3 Merck Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Cipla
13.2.1 Cipla Company Information
13.2.2 Cipla Montelukast API Product Offered
13.2.3 Cipla Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cipla Main Business Overview
13.2.5 Cipla Latest Developments
13.3 Morepen Laboratories
13.3.1 Morepen Laboratories Company Information
13.3.2 Morepen Laboratories Montelukast API Product Offered
13.3.3 Morepen Laboratories Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Morepen Laboratories Main Business Overview
13.3.5 Morepen Laboratories Latest Developments
13.4 Sun Pharma
13.4.1 Sun Pharma Company Information
13.4.2 Sun Pharma Montelukast API Product Offered
13.4.3 Sun Pharma Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sun Pharma Main Business Overview
13.4.5 Sun Pharma Latest Developments
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Information
13.5.2 Teva Pharmaceutical Industries Montelukast API Product Offered
13.5.3 Teva Pharmaceutical Industries Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teva Pharmaceutical Industries Main Business Overview
13.5.5 Teva Pharmaceutical Industries Latest Developments
13.6 Intas Pharmaceuticals
13.6.1 Intas Pharmaceuticals Company Information
13.6.2 Intas Pharmaceuticals Montelukast API Product Offered
13.6.3 Intas Pharmaceuticals Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Intas Pharmaceuticals Main Business Overview
13.6.5 Intas Pharmaceuticals Latest Developments
13.7 Apotex
13.7.1 Apotex Company Information
13.7.2 Apotex Montelukast API Product Offered
13.7.3 Apotex Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Apotex Main Business Overview
13.7.5 Apotex Latest Developments
13.8 Sanyo Chemical Industries
13.8.1 Sanyo Chemical Industries Company Information
13.8.2 Sanyo Chemical Industries Montelukast API Product Offered
13.8.3 Sanyo Chemical Industries Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanyo Chemical Industries Main Business Overview
13.8.5 Sanyo Chemical Industries Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Montelukast API Product Offered
13.9.3 Mylan Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Delmar Chemicals
13.10.1 Delmar Chemicals Company Information
13.10.2 Delmar Chemicals Montelukast API Product Offered
13.10.3 Delmar Chemicals Montelukast API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Delmar Chemicals Main Business Overview
13.10.5 Delmar Chemicals Latest Developments
14 Research Findings and Conclusion
Table 1. Montelukast API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Montelukast API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Chewable Tablet
Table 5. Major Players of Oral Solution
Table 6. Global Montelukast API Sales by Type (2017-2022) & (K Units)
Table 7. Global Montelukast API Sales Market Share by Type (2017-2022)
Table 8. Global Montelukast API Revenue by Type (2017-2022) & ($ million)
Table 9. Global Montelukast API Revenue Market Share by Type (2017-2022)
Table 10. Global Montelukast API Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Montelukast API Sales by Application (2017-2022) & (K Units)
Table 12. Global Montelukast API Sales Market Share by Application (2017-2022)
Table 13. Global Montelukast API Revenue by Application (2017-2022)
Table 14. Global Montelukast API Revenue Market Share by Application (2017-2022)
Table 15. Global Montelukast API Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Montelukast API Sales by Company (2020-2022) & (K Units)
Table 17. Global Montelukast API Sales Market Share by Company (2020-2022)
Table 18. Global Montelukast API Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Montelukast API Revenue Market Share by Company (2020-2022)
Table 20. Global Montelukast API Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Montelukast API Producing Area Distribution and Sales Area
Table 22. Players Montelukast API Products Offered
Table 23. Montelukast API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Montelukast API Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Montelukast API Sales Market Share Geographic Region (2017-2022)
Table 28. Global Montelukast API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Montelukast API Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Montelukast API Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Montelukast API Sales Market Share by Country/Region (2017-2022)
Table 32. Global Montelukast API Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Montelukast API Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Montelukast API Sales by Country (2017-2022) & (K Units)
Table 35. Americas Montelukast API Sales Market Share by Country (2017-2022)
Table 36. Americas Montelukast API Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Montelukast API Revenue Market Share by Country (2017-2022)
Table 38. Americas Montelukast API Sales by Type (2017-2022) & (K Units)
Table 39. Americas Montelukast API Sales Market Share by Type (2017-2022)
Table 40. Americas Montelukast API Sales by Application (2017-2022) & (K Units)
Table 41. Americas Montelukast API Sales Market Share by Application (2017-2022)
Table 42. APAC Montelukast API Sales by Region (2017-2022) & (K Units)
Table 43. APAC Montelukast API Sales Market Share by Region (2017-2022)
Table 44. APAC Montelukast API Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Montelukast API Revenue Market Share by Region (2017-2022)
Table 46. APAC Montelukast API Sales by Type (2017-2022) & (K Units)
Table 47. APAC Montelukast API Sales Market Share by Type (2017-2022)
Table 48. APAC Montelukast API Sales by Application (2017-2022) & (K Units)
Table 49. APAC Montelukast API Sales Market Share by Application (2017-2022)
Table 50. Europe Montelukast API Sales by Country (2017-2022) & (K Units)
Table 51. Europe Montelukast API Sales Market Share by Country (2017-2022)
Table 52. Europe Montelukast API Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Montelukast API Revenue Market Share by Country (2017-2022)
Table 54. Europe Montelukast API Sales by Type (2017-2022) & (K Units)
Table 55. Europe Montelukast API Sales Market Share by Type (2017-2022)
Table 56. Europe Montelukast API Sales by Application (2017-2022) & (K Units)
Table 57. Europe Montelukast API Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Montelukast API Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Montelukast API Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Montelukast API Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Montelukast API Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Montelukast API Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Montelukast API Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Montelukast API Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Montelukast API Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Montelukast API
Table 67. Key Market Challenges & Risks of Montelukast API
Table 68. Key Industry Trends of Montelukast API
Table 69. Montelukast API Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Montelukast API Distributors List
Table 72. Montelukast API Customer List
Table 73. Global Montelukast API Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Montelukast API Sales Market Forecast by Region
Table 75. Global Montelukast API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Montelukast API Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Montelukast API Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Montelukast API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Montelukast API Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Montelukast API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Montelukast API Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Montelukast API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Montelukast API Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Montelukast API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Montelukast API Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Montelukast API Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Montelukast API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Montelukast API Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Montelukast API Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Montelukast API Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Montelukast API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Montelukast API Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merck Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Montelukast API Product Offered
Table 95. Merck Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Cipla Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 99. Cipla Montelukast API Product Offered
Table 100. Cipla Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Cipla Main Business
Table 102. Cipla Latest Developments
Table 103. Morepen Laboratories Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 104. Morepen Laboratories Montelukast API Product Offered
Table 105. Morepen Laboratories Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Morepen Laboratories Main Business
Table 107. Morepen Laboratories Latest Developments
Table 108. Sun Pharma Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharma Montelukast API Product Offered
Table 110. Sun Pharma Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Sun Pharma Main Business
Table 112. Sun Pharma Latest Developments
Table 113. Teva Pharmaceutical Industries Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Industries Montelukast API Product Offered
Table 115. Teva Pharmaceutical Industries Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Teva Pharmaceutical Industries Main Business
Table 117. Teva Pharmaceutical Industries Latest Developments
Table 118. Intas Pharmaceuticals Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 119. Intas Pharmaceuticals Montelukast API Product Offered
Table 120. Intas Pharmaceuticals Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Intas Pharmaceuticals Main Business
Table 122. Intas Pharmaceuticals Latest Developments
Table 123. Apotex Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Montelukast API Product Offered
Table 125. Apotex Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Apotex Main Business
Table 127. Apotex Latest Developments
Table 128. Sanyo Chemical Industries Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 129. Sanyo Chemical Industries Montelukast API Product Offered
Table 130. Sanyo Chemical Industries Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Sanyo Chemical Industries Main Business
Table 132. Sanyo Chemical Industries Latest Developments
Table 133. Mylan Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan Montelukast API Product Offered
Table 135. Mylan Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Mylan Main Business
Table 137. Mylan Latest Developments
Table 138. Delmar Chemicals Basic Information, Montelukast API Manufacturing Base, Sales Area and Its Competitors
Table 139. Delmar Chemicals Montelukast API Product Offered
Table 140. Delmar Chemicals Montelukast API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Delmar Chemicals Main Business
Table 142. Delmar Chemicals Latest Developments
List of Figures
Figure 1. Picture of Montelukast API
Figure 2. Montelukast API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast API Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Montelukast API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Montelukast API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Chewable Tablet
Figure 11. Product Picture of Oral Solution
Figure 12. Global Montelukast API Sales Market Share by Type in 2021
Figure 13. Global Montelukast API Revenue Market Share by Type (2017-2022)
Figure 14. Montelukast API Consumed in Asthma
Figure 15. Global Montelukast API Market: Asthma (2017-2022) & (K Units)
Figure 16. Montelukast API Consumed in Allergic Rhinitis
Figure 17. Global Montelukast API Market: Allergic Rhinitis (2017-2022) & (K Units)
Figure 18. Montelukast API Consumed in Urticaria
Figure 19. Global Montelukast API Market: Urticaria (2017-2022) & (K Units)
Figure 20. Montelukast API Consumed in Bronchospasm
Figure 21. Global Montelukast API Market: Bronchospasm (2017-2022) & (K Units)
Figure 22. Montelukast API Consumed in Others
Figure 23. Global Montelukast API Market: Others (2017-2022) & (K Units)
Figure 24. Global Montelukast API Sales Market Share by Application (2017-2022)
Figure 25. Global Montelukast API Revenue Market Share by Application in 2021
Figure 26. Montelukast API Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Montelukast API Revenue Market Share by Company in 2021
Figure 28. Global Montelukast API Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Montelukast API Revenue Market Share by Geographic Region in 2021
Figure 30. Global Montelukast API Sales Market Share by Region (2017-2022)
Figure 31. Global Montelukast API Revenue Market Share by Country/Region in 2021
Figure 32. Americas Montelukast API Sales 2017-2022 (K Units)
Figure 33. Americas Montelukast API Revenue 2017-2022 ($ Millions)
Figure 34. APAC Montelukast API Sales 2017-2022 (K Units)
Figure 35. APAC Montelukast API Revenue 2017-2022 ($ Millions)
Figure 36. Europe Montelukast API Sales 2017-2022 (K Units)
Figure 37. Europe Montelukast API Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Montelukast API Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Montelukast API Revenue 2017-2022 ($ Millions)
Figure 40. Americas Montelukast API Sales Market Share by Country in 2021
Figure 41. Americas Montelukast API Revenue Market Share by Country in 2021
Figure 42. United States Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Montelukast API Sales Market Share by Region in 2021
Figure 47. APAC Montelukast API Revenue Market Share by Regions in 2021
Figure 48. China Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Montelukast API Sales Market Share by Country in 2021
Figure 55. Europe Montelukast API Revenue Market Share by Country in 2021
Figure 56. Germany Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Montelukast API Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Montelukast API Revenue Market Share by Country in 2021
Figure 63. Egypt Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Montelukast API Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Montelukast API in 2021
Figure 69. Manufacturing Process Analysis of Montelukast API
Figure 70. Industry Chain Structure of Montelukast API
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...